Protect IP To Encourage Switching In Australia, Urges ASMI

12 Feb 2019

The Australian Self Medication Industry (ASMI) is calling for IP protection for successful prescription-to-OTC reclassification applications to encourage switching in Australia.

The Australian Self Medication Industry (ASMI) has called for greater measures to protect intellectual property (IP) investment within the country’s prescription-to-OTC reclassification application process.

Forming part of its ‘2019-20 Pre-Budget Submission,’ the ASMI recommended to the Australian Treasury that the country’s medicines regulation should...